| Literature DB >> 29988893 |
Nan Chen1, Yi-Fan Peng2, Yun-Feng Yao2, Jin Gu2.
Abstract
AIM: To evaluate the feasibility and safety of trans-anal minimally invasive surgery (TAMIS) from single institute in China.Entities:
Keywords: Rectal neoplasia; Resection margin; Trans-anal minimally invasive surgery
Year: 2018 PMID: 29988893 PMCID: PMC6033710 DOI: 10.4251/wjgo.v10.i6.137
Source DB: PubMed Journal: World J Gastrointest Oncol
Figure 1Settings for trans-anal minimally invasive surgery. The SILS-Port® was inserted through the anus. Assisting trocars and routine laparoscopic instruments were placed. A high-definition 30º 5 mm or 10 mm laparoscopic camera lens was chosen. SILS: Single incision laparoscopic surgery.
Figure 2Procedures of trans-anal minimally invasive surgery. A: Intra-operative view of TAMIS showed resection margin was marked by electrocautery; B: An endoscopic grasper and electrocautery were used to facilitate a fullthickness excision; C: The defect of rectal wall was closed using STRATAFIXTM; D: The surgical specimen was pinned on plastic board with indicative orientation. TAMIS: Trans-anal minimally invasive surgery.
Patients’ clinical and pathological characteristics
| Mean age, yr (SD) | 55.3 (7.5) | 51.3 (13.8) | 51.8 (13.2) |
| Gender | |||
| Male | 1 | 8 | 10 (40%) |
| Female | 2 | 14 | 15 (60%) |
| Mean body mass index, kg/m2 (SD) | 23.9 (1.3) | 23.9 (3.0) | 23.9 (2.9) |
| Pre-TAMIS excision | 0 | 5 | 5 (20%) |
| Mean lesion size, cm (SD) | 1.1 (0.7) | 1.1 (0.5) | 1.1 (0.5) |
| Mean distance from anal verge, cm (SD) | 9.3 (0.6) | 8.3 (1.6) | 8.4 (1.6) |
| Final pathology | |||
| Benign | 3 | 3 (12%) | |
| Malignant | 22 (88%) | ||
| Adenocarcinoma | 6 | 6 (24%) | |
| Mid-high differentiation | 6 | 6 (24%) | |
| Low differentiation | 0 | 0 | |
| T0 (no residual tumor) | 0 | 0 | |
| T1 | 5 | 5 (20%) | |
| T2-3 | 1 | 1 (4%) | |
| NET | 16 | 16 (64%) | |
| Lymph-vascular invasion | 0 | 1 | 1 (4%) |
| Positive margin | 0 | 5 | 5 (20%) |
| Position | |||
| Lloyd-Davies | 3 | 15 | 18 (72%) |
| Jackknife | 0 | 7 | 7 (28%) |
| Mean duration of surgery, min (SD) | 58.0 (37.0) | 61.8 (24.7) | 61.3 (25.5) |
| Mean blood loss, mL (SD) | 5 (0) | 8.6 (4.4) | 8.2 (4.3) |
| Mean length of post-operative stay | 2.3 (1.5) | 2.8 (1.4) | 2.7 (1.4) |
Includes in situ and invasive adenocarcinoma and neuroendocrine tumors. NET: Neuroendocrine tumors.
Figure 3Correlation between cases and duration of trans-anal minimally invasive surgery surgeries. The X-axis represented individual case consequently, while the Y-axis was the duration of each surgery (min), indicating the learning curve of this technique.
Characteristics of patients with positive resection margin
| 1 | 58 | 2 | 19.9 | 7 | 2 | 50 | Lloyd-Davies | 1 | Lateral | Adenocarcinoma | Curative surgery |
| 2 | 75 | 2 | 23.2 | 10 | 2 | 60 | Lloyd-Davies | 1 | Basal | NET-G1 | Imatinib |
| 3 | 64 | 2 | 26.1 | 6 | 1.5 | 45 | Lloyd-Davies | 4 | Basal | NET-G1 | Imatinib |
| 4 | 63 | 2 | 20.0 | 10 | 0.5 | 60 | Lloyd-Davies | 2 | Lateral | NET-G1 | Imatinib |
| 5 | 59 | 1 | 24.8 | 8 | 1.5 | 30 | Lloyd-Davies | 3 | Lateral | Adenocarcinoma | Chemo-radiation |
NET: Neuroendocrine tumors.